S

Surrozen
D

SRZN

9.38000
USD
0.28
(3.08%)
Market Closed
Volume
16,821
EPS
0
Div Yield
-
P/E
-1
Market Cap
30,483,105
OverviewSignalsIdeasNews
News

Title: Surrozen

Sector: Healthcare
Industry: Biotechnology
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).